Michael S. Magee

Site-specific N-Linked Glycosylation of Receptor Guanylyl Cyclase C Regulates Ligand Binding, Ligand-mediated Activation and Interaction with Vesicular Integral Membrane Protein 36, VIP36

Engineered receptors for soluble cellular communication and disease sensing

A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy

Cytokines in inflammatory bowel disease

Dendritic cells in cancer immunology and immunotherapy

Elements of cancer immunity and the cancer–immune set point

Products for the treatment of inflammatory bowel disease: a patent review (2013 – 2014)

IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism

Biological roles of glycans

Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential

Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer

Pyroptosis: mechanisms and diseases

Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?

MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma

CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment

LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription

Therapeutic vaccines for cancer: an overview of clinical trials

Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors

Immune checkpoint inhibitors: recent progress and potential biomarkers

Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cells

Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases

GUCY2C Opposes Systemic Genotoxic Tumorigenesis by Regulating AKT-Dependent Intestinal Barrier Integrity

A uroguanylin-GUCY2C endocrine axis regulates feeding in mice

Challenges to chimeric antigen receptor (CAR)-T cell therapy for cancer.

Colorectal cancer immunotherapy.